VISUAL FIELD DEFECTS SECONDARY TO CABERGOLINE USE IN A PATIENT WITH PITUITARY TUMOR
Prolactinoma is the most common functional pituitary macroadenoma. It is usually treated with dopaminergic agonists, among them cabergoline, which decreases tumor size and consequently the symptoms caused by the tumor. An uncommon complication to this treatment is alterations in the visual field. In...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pan-American Association of Ophthalmology
2015-02-01
|
| Series: | Vision Pan-America |
| Subjects: | |
| Online Access: | http://journals.sfu.ca/paao/index.php/journal/article/view/219 |